rxlist.com (Enlon ) Keywords Organophosphate Cholinesterase Inhibitors Echothiophate Trade Name: Phospholine Iodide Drug Class: Anticholinesterase ( Organophosphate ) Mechanism of Action: for topical use to enhance the effect of endogenously liberated acetylcholine in the iris, ciliary muscle, and other parasympathetically innervated structures of the eye Irreversible long-acting cholinesterase inhibitor It causes miosis, increases the outflow of aqueous humor, causes a fall in intraocular pressure, and potentiation of accommodation Indications: Historically used for treatment of glaucoma but currently very rarely used, and frequently regarded as obsolete for the routine treatment of glaucoma (Figure 1)
(2018) reviewed the angiogenic properties of BPC-157 across multiple preclinical models
Somtimes the test result (s) motivates a person to make changes but if the results did not educate and motivate then the test just added more information
However, these medications have several important limitations: (1) delayed onset of therapeutic action, typically requiring weeks to months for clinical effect
Francescone RB, Vendramini-Costa D, Franco-Barraza J, Wagner J, Muir A,Lau AN,Gabitova L, Pazina T,Gupta S, Luong TRDMalik R,Thapa RJ,Restifo D,Zhou Y,Cai KQ,Hensley HH,Tan Y,Kruger WD,Devarajan K, Balachandran S, Klein-Szanto AJ, Wang H, El-Deiry WS